Metraipolis › archive › dc_097bc6e47822

Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival — Europe PMC PMID:40985858

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40985858
DOI
10.1002/ijc.70168
License (as archived)
solo-consultazione
Archived
2026-11-09T19:48:24.806Z
SHA-256 of the archived text
54c9011723d012fae5c31325b81281345dcaeb6c6daaeec9d95762a2bdf8127b
Stable URL of this page
https://metraipolis.com/documento/dc_097bc6e47822

How to cite

Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival — Europe PMC PMID:40985858 — Europe PMC (en), https://europepmc.org/article/MED/40985858 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_097bc6e47822 (Metraipolis archive dc_097bc6e47822, sha256 54c9011723d012fae5c31325b81281345dcaeb6c6daaeec9d95762a2bdf8127b)
BibTeX
@misc{dc097bc6e47822,
  title = {Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival — Europe PMC PMID:40985858},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40985858},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_097bc6e47822; sha256 54c9011723d012fae5c31325b81281345dcaeb6c6daaeec9d95762a2bdf8127b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40985858. Agents can read the archived copy with the MCP tool read_document.